Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement. We will accommodate your request to the best of our ability.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested. Advance notification is required for dry ice shipping, and additional fees will apply.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
The specific tag type will be determined during production. If you require a particular tag, please inform us, and we will prioritize its development.
This protein is believed to be involved in the processing and regulated turnover of intracellular proteins. It catalyzes the removal of unsubstituted N-terminal amino acids from various peptides.
KEGG: neu:NE0441
STRING: 228410.NE0441
Question: How can researchers structurally characterize pepA in N. europaea, given limited homology to well-studied aminopeptidases?
Answer: Structural elucidation of pepA requires a multi-omics approach. First, sequence alignment with bacterial aminopeptidases (e.g., E. coli PepA) can identify conserved catalytic motifs (e.g., metal-binding residues). Second, heterologous expression in E. coli (using optimized primers for codon bias ) enables purification for X-ray crystallography or NMR spectroscopy. Challenges include resolving low homology regions, which may necessitate comparative modeling using ab initio prediction tools (e.g., Rosetta). Integration of genomic context—such as proximity to ammonia oxidation genes (amoCAB, hao) in the N. europaea genome —may reveal functional links to metabolic pathways.
Question: What experimental strategies can determine the role of pepA in N. europaea metabolism?
Answer: To elucidate pepA’s role, researchers should employ gene knockout/knockdown approaches (CRISPR-Cas9 or RNAi) in N. europaea, followed by metabolomic profiling under ammonia-rich vs. -limited conditions. Parallel proteomic analysis using LC-MS/MS can identify substrates or interacting partners. For instance, disruptions in peptide degradation pathways may reveal pepA’s involvement in protein turnover or nitrogen assimilation. Comparative studies with N. europaea mutants lacking pepA could highlight impacts on growth rates or nitrite production under varying oxygen levels .
Question: How should researchers address conflicting reports on pepA transcription levels across studies?
Answer: Discrepancies often arise from experimental conditions (e.g., oxygen availability, ammonia concentration). A systematic approach involves:
Quantitative RT-PCR with primers targeting pepA’s coding sequence .
Transcriptomic profiling to map pepA expression relative to core ammonia oxidation genes (amoA, haoA) .
Statistical modeling to correlate pepA expression with metabolic fluxes (e.g., CO₂ fixation, polyphosphate accumulation ).
For example, pepA upregulation under oxygen-limited growth may indicate a role in stress adaptation, warranting validation via mutant phenotyping.
Question: What factors influence the recombinant production of pepA in heterologous hosts?
Answer: Key parameters include:
Challenges like low solubility may require fusion partners (e.g., GST, MBP) or in vitro refolding protocols.
Question: How can pepA be leveraged to study nitrification or nitrogen cycling?
Answer: pepA’s role in peptide degradation suggests its utility in exploring:
Nitrogen assimilation: Tracking pepA activity in ammonia-rich environments could reveal its role in nitrogen scavenging.
Microbial community interactions: Co-culture experiments with heterotrophs may show pepA’s impact on dissolved organic nitrogen pools.
Biotechnological engineering: Overexpression of pepA in nitrifiers could enhance bioremediation efficiency in wastewater treatment.
Question: How does pepA’s genomic context vary among Nitrosomonas species?
Answer: A phylogenetic analysis of pepA across Nitrosomonas genomes (e.g., N. europaea, N. ureae) can reveal evolutionary pressures. For instance:
Such comparisons can highlight species-specific adaptations to environmental niches.
Question: What technical challenges arise when studying pepA in N. europaea?
Answer: Critical pitfalls include:
Low expression levels: Use promoter engineering (e.g., T7 lac promoter in E. coli) to enhance yield.
Contaminating proteases: Inclusion of protease inhibitors (e.g., EDTA, PMSF) during purification.
Functional redundancy: Distinguish pepA’s role from other aminopeptidases via knockout complementation.
Question: Which bioinformatics resources are essential for studying pepA?
Answer: Key tools include:
NCBI BLAST for homology searches and conserved domain identification.
SWISS-MODEL or Phyre2 for structure prediction from primary sequence.
KEGG or MetaCyc for pathway mapping relative to nitrogen metabolism.
PSORTb to predict subcellular localization (e.g., cytosol vs. periplasm).
Question: How can pepA be incorporated into metabolic flux models of N. europaea?
Answer: Researchers should:
Quantify pepA activity via enzyme assays (e.g., L-leucine-p-nitroanilide hydrolysis).
Integrate kinetic parameters into genome-scale metabolic models (GSMs).
Simulate peptide degradation fluxes under ammonia-rich vs. -limited conditions to predict pepA’s regulatory role.
Question: What biosafety protocols are necessary when working with recombinant pepA?
Answer: Since N. europaea is non-pathogenic, standard BL1 containment suffices. Recombinant pepA in E. coli requires adherence to BL2 guidelines, including autoclaving waste and using appropriate PPE. Ethical considerations focus on environmental impact—avoiding unintended release of engineered nitrifiers into natural systems.